TREM2 and amyloidosis: This positive correlation is in line with previous research conducted in AD mouse models that revealed upregulation of TREM2 mRNA in the amyloid plaque boundaries [17], and those performed on human brain samples that showed positive correlation between TREM2 mRNA levels and p-tau burden in mid-temporal gyrus from AD patients [21].